OPX生物技術(shù)公司

公司收入：不詳

公司總部：科羅拉多州博爾德

所屬行業(yè)：可再生化學品

成立時間：2007年

員工人數(shù)：47人

????大部分人把大腸桿菌當作是致病細菌,，但是OPX公司的視角卻與眾不同?？偛课挥诓柕碌倪@家生物技術(shù)公司把經(jīng)過基因方法改造的大腸桿菌與玉米和甘蔗進行混合,，生產(chǎn)一系列的農(nóng)作物化工產(chǎn)品，替代成本高昂的石油化工產(chǎn)品,。該公司的首個產(chǎn)品是生物丙烯酸——石油丙烯酸的替代品——廣泛應用于油漆,、粘合劑和尿片生產(chǎn)。最近,，OPX公司獲得了3,，650萬美元的風險投資，并宣布與陶氏化學公司（Dow Chemical）建立了合作伙伴關(guān)系,。它計劃在2014年建成首個規(guī)?；S。CEO查斯?艾格特稱,，丙烯酸的全球產(chǎn)值為80億美元,，年增長率為3%至4%。他說：“我們的目標是成為世界可再生化工產(chǎn)品行業(yè)的領袖,，并涉足多個領域,。”即便如此,，在這個熱門領域,，該公司面臨著來自生物基化學公司Genomatica和BioAmber公司的激烈競爭。

????——理查德?麥吉爾?墨菲

OPX Biotechnology

Revenue: Not available

Headquarters: Boulder, Colo.

Industry: Renewable chemicals

Founded: 2007

Employees: 47

????Most people think of e-coli as a yucky bacteria that can make you sick, but that's not how OPX sees it. The Boulder-based biotech blends genetically engineered e-coli with corn or sugarcane to produce a range of plant-based chemicals that replace more expensive petroleum-based compounds. The company's first commercial product is bioacrylic, a sub for petroleum-based acrylic acid, a common ingredient in paints, adhesives, and diapers. OPX recently raised $36.5 million in venture capital and recently announced a partnership with Dow Chemical. It plans to open its first industrial-scale plant in 2014. According to CEO Chas Eggert, the global market for acrylic acid is about $8 billion, growing at an annual rate of 3% to 4%. "We want to be the world leader in renewable chemicals, with a broad portfolio," he says. Even so, the company operates in a crowded field with tough competition from Genomatica and BioAmber.

????--R.M.M.